Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-20

Clinical Trial Update: A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) [Phase 3]

View source ↗

Summary

A Phase 3 platform trial in pediatric participants with obesity or overweight is currently recruiting; no results are reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: RECRUITING